Glioma klinikiniai tyrimai Ilinoisas
13 tyrimai dėl Glioma ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- University of Chicago Comprehensive Cancer Center, Chicago
- OSF Children's Hospital of Illinois, Peoria
Renkami dalyviai1/2 fazė
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-10-01 · NCT05099003Targeted Pediatric High-Grade Glioma Therapy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviaiStebimasis tyrimas
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-09-08 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai2 fazė
Amžius nuo 12 iki 39 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Chicago, Chicago
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai2 fazė
Amžius nuo 3 iki 39 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai1 fazė
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-08-18 · NCT04485559Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Chicago
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-08-12 · NCT05417594A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Northwestern Medicine, Chicago
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-30 · NCT07464925MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai1/2 fazė
Amžius nuo 1 iki 26 · Visoms lytims · Atnaujinta 2026-07-10 · NCT06712875Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2026-06-29 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai2 fazė
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-05-29 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Northwestern Memorial Hospital, Chicago
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT06810544rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai1 fazė
12 Months – 18 Years · Visoms lytims · Atnaujinta 2026-03-17 · NCT04943848Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.